Carcinoma in situ of bladder (disorder)
BOXIT-T is the translational arm of the BOXIT randomised double-blind placebo-controlled trial evaluating the addition of celecoxib, a COX-2 inhibitor, to standard therapy for high and intermediate risk non-invasive bladder cancer.
Year Started: 2007
Paraffin embedded tissue, Fresh tissue, Blood samples, Urine samples
- Access:
- Open to applicants
- Type:
- Clinical Trial
- Status:
- Completed
- Consent restrictions:
- No restrictions
Associated Data Type | Procurement Timeframe |
---|---|
There is no associated data for this collection. |
Unknown
Adult (> 40 years)
101 - 500 donors
Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
---|---|---|---|---|---|
There are no material preservation details for this sample set |